クアンタム・シイ
Quantum-Si incorporated
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.11 | $344,000 | -$19M |
| 2026 Q1 | -0.10 | $258,000 | -$26M |
| 2025 Q4 | -0.08 | $451,000 | -$16M |
| 2025 Q3 | -0.17 | $552,000 | -$33M |
| 2025 Q2 | -0.16 | $591,000 | -$21M |
| 2025 Q1 | -0.11 | $842,000 | -$27M |
| 2024 Q4 |
| -0.23 |
| $1M |
| -$24M |
| 2024 Q3 | -0.18 | $787,000 | -$24M |